Search details
1.
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.
Europace
; 26(4)2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38558121
2.
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
Eur Heart J
; 42(29): 2842-2850, 2021 07 31.
Article
in English
| MEDLINE | ID: mdl-34113975
3.
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
J Card Fail
; 21(11): 930-4, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26216495
4.
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Am Heart J
; 168(1): 30-6, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24952857
5.
ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy.
Heart Rhythm
; 2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-38403235
6.
Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2-year experience.
ESC Heart Fail
; 10(1): 594-600, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36377206
7.
Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.
ESC Heart Fail
; 7(3): 892-902, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32159279
Results
1 -
7
de 7
1
Next >
>>